PPP Stock Overview
Engages in the production, sale, and distribution of medicines primarily in Vietnam.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Phong Phu Pharmaceutical Joint Stock Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₫16,600.00 |
| 52 Week High | ₫20,600.00 |
| 52 Week Low | ₫13,000.00 |
| Beta | -0.18 |
| 1 Month Change | -8.29% |
| 3 Month Change | 5.06% |
| 1 Year Change | 22.06% |
| 3 Year Change | 43.10% |
| 5 Year Change | 32.32% |
| Change since IPO | 73.90% |
Recent News & Updates
Recent updates
Shareholder Returns
| PPP | VN Pharmaceuticals | VN Market | |
|---|---|---|---|
| 7D | -1.2% | 1.5% | 2.3% |
| 1Y | 22.1% | 15.2% | 18.1% |
Return vs Industry: PPP exceeded the VN Pharmaceuticals industry which returned 15.2% over the past year.
Return vs Market: PPP exceeded the VN Market which returned 18.1% over the past year.
Price Volatility
| PPP volatility | |
|---|---|
| PPP Average Weekly Movement | 5.2% |
| Pharmaceuticals Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in VN Market | 7.3% |
| 10% least volatile stocks in VN Market | 2.6% |
Stable Share Price: PPP has not had significant price volatility in the past 3 months.
Volatility Over Time: PPP's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | n/a | n/a | duocphongphu.vn |
Phong Phu Pharmaceutical Joint Stock Company engages in the production, sale, and distribution of medicines primarily in Vietnam. The company’s medicines are derived from medicinal herbs, pharmaceutical chemicals, and health protection food, that are offered in tablets, film-coated, sugar-coated, soft capsules, granules, powder, and other forms. It offers its products for respiratory, spiritual, anti-inflammatory, anti-allergic, digest, cardiovascular, diabetes, liver function, and osteoarthritis, as well as provides vitamins and minerals.
Phong Phu Pharmaceutical Joint Stock Company Fundamentals Summary
| PPP fundamental statistics | |
|---|---|
| Market cap | ₫146.08b |
| Earnings (TTM) | ₫17.98b |
| Revenue (TTM) | ₫145.98b |
8.1x
P/E Ratio1.0x
P/S RatioIs PPP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PPP income statement (TTM) | |
|---|---|
| Revenue | ₫145.98b |
| Cost of Revenue | ₫98.94b |
| Gross Profit | ₫47.05b |
| Other Expenses | ₫29.06b |
| Earnings | ₫17.98b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.04k |
| Gross Margin | 32.23% |
| Net Profit Margin | 12.32% |
| Debt/Equity Ratio | 0% |
How did PPP perform over the long term?
See historical performance and comparison